Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Smits

Showing results (241-250 of 295) with videos related to

Pageof 30
Sort By:
JACC. Cardiovascular Interventions|June 25, 2016
Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II TrialYohei Sotomi, Yuki Ishibashi, Pannipa Suwannasom, et al.
Circulation|March 23, 2005
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH)Marco Valgimigli, Carlos A G van Mieghem, Andrew T L Ong, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|July 23, 2011
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-upJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Journal of Clinical Medicine|October 28, 2023
Direct Stenting versus Conventional Stenting in Patients with ST-Segment Elevation Myocardial Infarction-A COMPARE CRUSH Sub-StudyRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
JACC. Cardiovascular Interventions|June 25, 2021
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial InfarctionRosanne F Vogel, Ronak Delewi, Dominick J Angiolillo, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes MellitusAlexander Thomas, Dean J Kereiakes, Andreas Baumbach, et al.
American Heart Journal|June 7, 2022
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trialRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial areaJeroen M Wilschut, Rosanne F Vogel, Jacob J Elscot, et al.
European Heart Journal|January 1, 2019
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient dataFrederik M Zimmermann, Elmir Omerovic, Stephane Fournier, et al.
Pageof 30

Showing results (241-250 of 295) with videos related to

Sort By:
Pageof 30
JACC. Cardiovascular Interventions|June 25, 2016
Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II TrialYohei Sotomi, Yuki Ishibashi, Pannipa Suwannasom, et al.
Circulation|March 23, 2005
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH)Marco Valgimigli, Carlos A G van Mieghem, Andrew T L Ong, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|July 23, 2011
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-upJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Journal of Clinical Medicine|October 28, 2023
Direct Stenting versus Conventional Stenting in Patients with ST-Segment Elevation Myocardial Infarction-A COMPARE CRUSH Sub-StudyRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
JACC. Cardiovascular Interventions|June 25, 2021
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial InfarctionRosanne F Vogel, Ronak Delewi, Dominick J Angiolillo, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes MellitusAlexander Thomas, Dean J Kereiakes, Andreas Baumbach, et al.
American Heart Journal|June 7, 2022
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trialRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial areaJeroen M Wilschut, Rosanne F Vogel, Jacob J Elscot, et al.
European Heart Journal|January 1, 2019
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient dataFrederik M Zimmermann, Elmir Omerovic, Stephane Fournier, et al.
Pageof 30